The field of gene and cell therapy is experiencing a renaissance, with innovations in the use of viral vectors as a gene delivery vehicle being a key factor in the field’s growth. However, the long-term impact of viral vectors requires continuing research into their design that addresses both efficacy and the problems associated with immunogenicity and toxicity.
